Literature DB >> 15709124

Differential chemosensitivity of tumor components in a malignant oligodendroglioma: assessment with diffusion-weighted, perfusion-weighted, and serial volumetric MR imaging.

Hans Rolf Jäger1, Adam D Waldman, Christopher Benton, Nicholas Fox, Jeremy Rees.   

Abstract

We report the case of malignant oligodendroglioma in a 36-year-old man who underwent diffusion-weighted, perfusion-weighted, and volumetric MR imaging before and after PCV (procarbazine, CCNU, vincristine) chemotherapy. The tumor regions exhibiting a low apparent diffusion coefficient and increased relative cerebral blood volume showed a marked response to chemotherapy and dramatic decrease in volume, whereas the remaining tumor regions showed little change. Diffusion-weighted and perfusion-weighted MR imaging may be helpful in predicting chemosensitivity of glial tumors.

Entities:  

Mesh:

Year:  2005        PMID: 15709124      PMCID: PMC7974071     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

Review 1.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Authors:  Soonmee Cha; Edmond A Knopp; Glyn Johnson; Stephan G Wetzel; Andrew W Litt; David Zagzag
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

2.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

3.  Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders.

Authors:  P A Freeborough; R P Woods; N C Fox
Journal:  J Comput Assist Tomogr       Date:  1996 Nov-Dec       Impact factor: 1.826

4.  Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.

Authors:  L D Stegman; A Rehemtulla; D A Hamstra; D J Rice; S J Jonas; K L Stout; T L Chenevert; B D Ross
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

5.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

Review 6.  Primary brain tumours in adults.

Authors:  Anthony Behin; Khe Hoang-Xuan; Antoine F Carpentier; Jean-Yves Delattre
Journal:  Lancet       Date:  2003-01-25       Impact factor: 79.321

7.  Effect of hydrophilic components of the extracellular matrix on quantifiable diffusion-weighted imaging of human gliomas: preliminary results of correlating apparent diffusion coefficient values and hyaluronan expression level.

Authors:  Niloufar Sadeghi; Isabelle Camby; Serge Goldman; Hans-Joachim Gabius; Danielle Balériaux; Isabelle Salmon; Christine Decaesteckere; Robert Kiss; Thierry Metens
Journal:  AJR Am J Roentgenol       Date:  2003-07       Impact factor: 3.959

8.  Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.

Authors:  D Yang; Y Korogi; T Sugahara; M Kitajima; Y Shigematsu; L Liang; Y Ushio; M Takahashi
Journal:  Neuroradiology       Date:  2002-06-29       Impact factor: 2.804

9.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Authors:  Meng Law; Stanley Yang; Hao Wang; James S Babb; Glyn Johnson; Soonmee Cha; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

10.  Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.

Authors:  S Cha; E A Knopp; G Johnson; A Litt; J Glass; M L Gruber; S Lu; D Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

View more
  10 in total

Review 1.  Multicentre imaging measurements for oncology and in the brain.

Authors:  P S Tofts; D J Collins
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 2.  Diffusion-weighted MRI for assessment of early cancer treatment response.

Authors:  Stefanie Galbán; Jean-Christophe Brisset; Alnawaz Rehemtulla; Thomas L Chenevert; Brian D Ross; Craig J Galbán
Journal:  Curr Pharm Biotechnol       Date:  2010-09-01       Impact factor: 2.837

Review 3.  Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.

Authors:  G Thompson; S J Mills; D J Coope; J P B O'Connor; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 4.  Conventional MRI evaluation of gliomas.

Authors:  N Upadhyay; A D Waldman
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

5.  Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors.

Authors:  Jayant Narang; Rajan Jain; Lisa Scarpace; Sona Saksena; Lonni R Schultz; Jack P Rock; Mark Rosenblum; Suresh C Patel; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2010-08-01       Impact factor: 4.130

6.  Conventional and advanced (DTI/SWI) neuroimaging findings in pediatric oligodendroglioma.

Authors:  Matthias W Wagner; Andrea Poretti; Thierry A G M Huisman; Thangamadhan Bosemani
Journal:  Childs Nerv Syst       Date:  2015-03-27       Impact factor: 1.475

7.  Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype.

Authors:  Michael D Jenkinson; Daniel G du Plessis; Trevor S Smith; Andrew R Brodbelt; Kathy A Joyce; Carol Walker
Journal:  J Neurooncol       Date:  2009-07-19       Impact factor: 4.130

Review 8.  Diffusion MRI in early cancer therapeutic response assessment.

Authors:  C J Galbán; B A Hoff; T L Chenevert; B D Ross
Journal:  NMR Biomed       Date:  2016-01-15       Impact factor: 4.044

9.  Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.

Authors:  Michael D Jenkinson; Trevor S Smith; Kathy A Joyce; Diane Fildes; John Broome; Daniel G du Plessis; Brian Haylock; David J Husband; Peter C Warnke; Carol Walker
Journal:  Neuroradiology       Date:  2006-08-26       Impact factor: 2.804

10.  Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.

Authors:  C Walker; B Haylock; D Husband; K A Joyce; D Fildes; M D Jenkinson; T Smith; J Broome; K Kopitzki; D G du Plessis; J Prosser; S Vinjamuri; P C Warnke
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.